These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
205 related articles for article (PubMed ID: 29047309)
1. Chimpanzee adenoviral vectors as vaccines - challenges to move the technology into the fast lane. Vitelli A; Folgori A; Scarselli E; Colloca S; Capone S; Nicosia A Expert Rev Vaccines; 2017 Dec; 16(12):1241-1252. PubMed ID: 29047309 [TBL] [Abstract][Full Text] [Related]
2. Development of novel vaccine vectors: Chimpanzee adenoviral vectors. Guo J; Mondal M; Zhou D Hum Vaccin Immunother; 2018 Jul; 14(7):1679-1685. PubMed ID: 29300685 [TBL] [Abstract][Full Text] [Related]
3. A CD46-binding chimpanzee adenovirus vector as a vaccine carrier. Tatsis N; Blejer A; Lasaro MO; Hensley SE; Cun A; Tesema L; Li Y; Gao GP; Xiang ZQ; Zhou D; Wilson JM; Ertl HC Mol Ther; 2007 Mar; 15(3):608-17. PubMed ID: 17228314 [TBL] [Abstract][Full Text] [Related]
4. Chimpanzee adenoviral vectors as vaccines for outbreak pathogens. Ewer K; Sebastian S; Spencer AJ; Gilbert S; Hill AVS; Lambe T Hum Vaccin Immunother; 2017 Dec; 13(12):3020-3032. PubMed ID: 29083948 [TBL] [Abstract][Full Text] [Related]
5. Effect of preexisting immunity to adenovirus human serotype 5 antigens on the immune responses of nonhuman primates to vaccine regimens based on human- or chimpanzee-derived adenovirus vectors. McCoy K; Tatsis N; Korioth-Schmitz B; Lasaro MO; Hensley SE; Lin SW; Li Y; Giles-Davis W; Cun A; Zhou D; Xiang Z; Letvin NL; Ertl HC J Virol; 2007 Jun; 81(12):6594-604. PubMed ID: 17428852 [TBL] [Abstract][Full Text] [Related]
10. Characterization of a family of chimpanzee adenoviruses and development of molecular clones for gene transfer vectors. Roy S; Gao G; Lu Y; Zhou X; Lock M; Calcedo R; Wilson JM Hum Gene Ther; 2004 May; 15(5):519-30. PubMed ID: 15144581 [TBL] [Abstract][Full Text] [Related]
11. Development of Novel Vaccines Against Infectious Diseases Based on Chimpanzee Adenoviral Vector. Zhang C; Chi Y; Zhou D Methods Mol Biol; 2017; 1581():3-13. PubMed ID: 28374240 [TBL] [Abstract][Full Text] [Related]
12. Development of replication-deficient adenovirus malaria vaccines. Hollingdale MR; Sedegah M; Limbach K Expert Rev Vaccines; 2017 Mar; 16(3):261-271. PubMed ID: 27606709 [TBL] [Abstract][Full Text] [Related]
13. Innate Immune Responses to Chimpanzee Adenovirus Vector 155 Vaccination in Mice and Monkeys. Collignon C; Bol V; Chalon A; Surendran N; Morel S; van den Berg RA; Capone S; Bechtold V; Temmerman ST Front Immunol; 2020; 11():579872. PubMed ID: 33329551 [TBL] [Abstract][Full Text] [Related]
14. Factors Which Contribute to the Immunogenicity of Non-replicating Adenoviral Vectored Vaccines. Coughlan L Front Immunol; 2020; 11():909. PubMed ID: 32508823 [TBL] [Abstract][Full Text] [Related]